Streetbeat News

Analyst Ratings

LLY

Morgan Stanley analyst David Phung has maintained an Overweight rating on Eli Lilly (NYSE:LLY) and raised the price target from $617 to $640.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 2:47 pm

LULU

A significant amount of unusual options activity has been observed for Lululemon Athletica (NASDAQ:LULU), with a predominantly bearish stance. Whales have been targeting a price range from $360.0 to $420.0 for Lululemon over the last 3 months. The current price of LULU is down -0.93% at $400.42. Several financial institutions have maintained their positive ratings on Lululemon, with price targets ranging from $366 to $480.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 2:46 pm

SQ

A whale investor has taken a bullish stance on Block (NYSE:SQ), with 72% of the investors opening trades with bullish expectations and 27% with bearish. The whale has been targeting a price range from $55.0 to $87.5 for Block over the last 3 months. The price of SQ is up 0.81% at $58.64. Analysts have mixed ratings on Block, with price targets ranging from $70 to $90.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 2:46 pm

LLY

Unusual options activity has been observed for Eli Lilly (NYSE:LLY), with a bearish stance taken by a large investor. The options scanner at Benzinga spotted 14 uncommon trades, with a sentiment split of 35% bullish and 64% bearish. The whales have been targeting a price range from $250.0 to $600.0 for Eli Lilly over the last 3 months. Current price of LLY is $560.93, up 0.69%. Analysts from Goldman Sachs, Credit Suisse, Wells Fargo, and Cantor Fitzgerald have maintained their ratings on Eli Lilly, with price targets ranging from $470 to $630.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 2:46 pm

PLTR

Palantir Technologies Inc (NYSE:PLTR) shares have seen a 15% loss over the last month, following a downgrade from Morgan Stanley analyst Keith Weiss from Equal-Weight to Underweight, despite a raised price target from $8 to $9. The recent pullback in Palantir is likely due to a broader cooldown in AI-related stocks. Cathie Wood, founder, CEO and CIO of Ark Invest, bought more than 673,000 shares across three Ark funds last week.

Portfolio Pulse from Adam Eckert

September 05, 2023 | 2:44 pm

CPHC

EXPR

GM

IP

WEYS

Benzinga Insights has identified five value stocks in the consumer cyclical sector that may be worth watching: International Paper (NYSE:IP), General Motors (NYSE:GM), Express (NYSE:EXPR), Weyco Group (NASDAQ:WEYS), and Canterbury Park Holding (NASDAQ:CPHC). The selection was based on quantified analysis, considering factors such as P/E multiples, earnings per share, and dividend yield.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 2:43 pm

BIIB

Morgan Stanley analyst Matthew Harrison maintains an Overweight rating on Biogen (NASDAQ:BIIB) and raises the price target from $363 to $381.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 2:41 pm

VS

HC Wainwright & Co. analyst Scott Buck has reiterated a Neutral rating on Versus Systems (NASDAQ:VS) and maintained a $0.5 price target.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 2:40 pm

RXRX

Needham analyst Gil Blum has reiterated a 'Buy' rating on Recursion Pharmaceuticals (NASDAQ:RXRX) and maintained a price target of $17.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 2:38 pm

SLRN

Morgan Stanley analyst Vikram Purohit maintains an Overweight rating on Acelyrin (NASDAQ:SLRN) and raises the price target from $29 to $39.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 2:37 pm